Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.

Leukemia - 1 Sept 1994

Preudhomme C, Lubin R, Lepelley P, Vanrumbeke M, Fenaux P

Abstract excerpt

In solid tumors, p53 antibodies are found in 30% of the patients with p53 mutations, and their analysis is an interesting method for the detection of p53 mutations. We looked for circulating p53 antibodies in 83 patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), by an ELISA technique. Detection of p53 mutations was made by single stranded conformation polymorphism (SSCP) analysis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Mutation

Share to Nucleic Acid Conformation

Share to Polymorphism, Genetic

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 8090036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.PMID 8090036Read ↗

Mutations in the p53 gene in myelodysplastic syndromes.Semantic proximity Read ↗

Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.Semantic proximity Read ↗

Mutations of the p53 tumour suppressor gene in haematologic neoplasms.Semantic proximity Read ↗

Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS).Semantic proximity Read ↗

P53 mutation in advanced stage of primary myelodysplastic syndrome.Semantic proximity Read ↗

Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.Semantic proximity Read ↗

Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.Semantic proximity Read ↗

Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.Semantic proximity Read ↗

Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.Semantic proximity Read ↗

P53 gene mutations in acute myelogenous leukaemia.Semantic proximity Read ↗

Mutations of the P53 gene in acute myeloid leukaemia.Semantic proximity Read ↗

Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor PrognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.